Zoom brings together in-office and remote employees with the launch of Intelligent Director for Zoom Rooms

AI-powered Intelligent Director enhances connection and optimizes the conference room experience for hybrid work, using multiple cameras to give every participant their own space in Zoom Meetings

SAN JOSE, Calif., June 27, 2023 (GLOBE NEWSWIRE) — Today Zoom Video Communications, Inc. (NASDAQ: ZM) announced the launch of the award-winning Intelligent Director for Zoom Rooms. For hybrid meetings with a Zoom Room, Intelligent Director uses AI and multiple cameras to provide the best image and angle of participants in the room so remote participants can see each person clearly, even in large conference rooms.

“As more people return to the office, it’s no longer enough to deliver the best remote worker experience; every business needs a solution to deliver the best hybrid meeting experience,” said Smita Hashim, chief product officer at Zoom. “Even with some employees in the office, oftentimes other team members are dispersed, so meeting equity and inclusion become more important than ever. Intelligent Director is the solution that can bring employees together, regardless of location, so they can truly connect face-to-face.”

Intelligent Director is specifically designed for medium- to larger-sized rooms and helps avoid the “bowling alley effect.” Intelligent Director can individually frame up to 16 participants in a Zoom Room using multiple cameras, choosing the best video stream via a Zoom-designed AI, and send that stream to the gallery view of the Zoom Meeting.

An evolution of Zoom’s Smart Gallery feature, which uses a single camera and AI to give each person in a small to medium-sized room their own space in a Zoom Meeting, Intelligent Director takes this same technology to the next level for larger conference rooms.

For bigger meeting spaces, it is easier to be hidden by others when only using a single camera, so Intelligent Director’s multi-camera configuration and use of video AI technology provide meeting equity to everyone in the room, selecting the best view of each individual, even if they move around or turn their heads. Remote participants can now have face-to-face conversations with each Zoom Rooms participant, allowing in-room participants to be seen and heard.

Intelligent Director is made possible through the support of Zoom’s hardware partner ecosystem. Manufacturers, including Apple, AVer, Dell, HP | Poly, Intel, Logitech, and Yealink have supported Zoom with the computer, controller, and camera solutions necessary to produce this major advancement.

About Zoom
Zoom is an all-in-one intelligent collaboration platform that makes connecting easier, more immersive, and more dynamic for businesses and individuals. Zoom technology puts people at the center, enabling meaningful connections, facilitating modern collaboration, and driving human innovation through solutions like team chat, phone, meetings, omnichannel cloud contact center, smart recordings, whiteboard, and more, in one offering. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more info at zoom.com.

Zoom Public Relations
Lacretia Taylor
press@zoom.us

GlobeNewswire Distribution ID 8865322

IAVI Starts First-in-Human Phase I Clinical Trial of Single-Dose Sudan Virus Vaccine Candidate

NEW YORK, NY / ACCESSWIRE / June 27, 2023 / IAVI announced today that the first participants have been vaccinated with a Sudan virus (SUDV) vaccine candidate in a first-in-human Phase I clinical trial in the U.S. The IAVI-sponsored trial is funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS).

Known as IAVI C108, this first-in-human study is designed to evaluate the safety and immunogenicity of an investigational SUDV vaccine candidate donated to IAVI by Merck (known as MSD outside the U.S. and Canada) to supplement IAVI’s ongoing SUDV vaccine development program. This investigational SUDV vaccine candidate was produced for IAVI from existing investigational bulk drug substance previously manufactured by Merck. IAVI is the vaccine candidate’s regulatory sponsor. IAVI is responsible for all aspects of the candidate’s future development, including demonstrating equivalence between this SUDV vaccine candidate and IAVI’s other SUDV vaccine candidate, which utilizes the same viral vector but is manufactured using a new production platform.

The SUDV vaccine candidate being evaluated in IAVI C108 uses the same recombinant vesicular stomatitis virus (rVSV) viral vector platform as ERVEBO®, Merck’s single-dose Zaire ebolavirus (ZEBOV) vaccine which is licensed in the U.S., U.K., European Union, Canada, Switzerland, and 10 African countries. rVSV is also the platform technology utilized in IAVI’s portfolio of emerging infectious disease (EID) candidates.

“IAVI C108 represents an important first step toward generating the data needed for eventual licensure of an rVSV-SUDV vaccine. The development and licensure of ERVEBO® has resulted in an important tool in Ebola Zaire outbreak response. If proven effective, we’re hopeful that a vaccine candidate built on the same viral platform will be similarly important in future SUDV outbreaks,” said Swati Gupta, Ph.D., vice president and head of emerging infectious diseases and epidemiology at IAVI. “In parallel, we must continue accelerating efforts toward the adequate availability of candidate vaccine doses for evaluation during and ahead of outbreaks with key partners, collaborators, and funders. We’re grateful to Merck for donating the doses that will be used in IAVI C108 and to BARDA for its support of this trial.”

IAVI C108 will take place at two U.S.-based clinical trial sites, where the study vaccine will be administered intramuscularly at three dosage levels. This is a placebo-controlled, single-blind study, meaning that only the researchers conducting the study will know whether a participant has received a vaccine dose or a placebo dose until after the trial is over. Approximately 36 healthy adults will be enrolled and will be followed for six months after vaccination to monitor their safety and immune responses to the vaccine candidate.

Like ZEBOV, SUDV is responsible for recurring viral hemorrhagic fever outbreaks, which have had lasting impacts on health security and geopolitical stability across sub-Saharan Africa. The estimated case fatality ratios of SUDV disease have varied from 41% to 100% in past outbreaks[1]. Despite high morbidity and mortality, there are no vaccines or therapeutics licensed for the prevention and treatment of SUDV. Existing ZEBOV vaccines and treatments are not effective against SUDV. Data being generated from ongoing studies suggest that rVSV could be a safe and effective platform for responding to SUDV and other related pathogens[2].

IAVI’s rVSV-based EID portfolio includes a SUDV vaccine candidate supported by BARDA; a Lassa fever virus vaccine candidate currently in a Phase I trial and supported by the Coalition for Epidemic Preparedness Innovations and the European & Developing Countries Clinical Trials Partnership; a Marburg virus vaccine candidate supported by BARDA and the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DOD); and an intranasal SARS-CoV-2 vaccine candidate supported by DOD DTRA and the Japan Ministry of Finance.

The rVSV platform has been used extensively in adults and children[3]. The underlying vesicular stomatitis virus (VSV) is a common animal virus that does not cause serious illness in humans and has been investigated extensively as a vaccine vector. In the vaccine platform, it is engineered to encode a surface protein from a target pathogen – in this case, SUDV – to prompt the body to mount an immune response.

Much of the research and development on IAVI’s rVSV platform is performed at the IAVI Vaccine Design and Development Lab (DDL) in Brooklyn, New York. The DDL is located at the bioscience center in the historic Brooklyn Army Terminal. Since its founding in 2008, the IAVI DDL has become one of the world’s leading viral vector vaccine research and development labs, known for innovation and generation of novel vaccine design concepts.

Scientists with IAVI’s Human Immunology Laboratory (HIL) in London, U.K., are involved in processing participant samples and developing the analytical assays needed to evaluate IAVI C108 participants’ immune responses. Established in 2001, the HIL is fully integrated into the Infectious Disease department within the Faculty of Medicine at Imperial College London and serves as the clinical immunology reference laboratory for IAVI and the network of clinical research centers with which IAVI collaborates worldwide.

Media Contact
Rose Catlos
Rcatlos@iavi.org
212-847-1049

About IAVI
IAVI is a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges including HIV, tuberculosis, and emerging infectious diseases. Its mission is to translate scientific discoveries into affordable, globally accessible public health solutions. Read more at iavi.org.

Follow IAVI on Facebook, LinkedIn, Instagram, and YouTube, and subscribe to our news updates.

About IAVI’s rVSV vaccine candidates
IAVI holds a nonexclusive license to the rVSV vaccine candidates from the Public Health Agency of Canada (PHAC). The vector was developed by scientists at PHAC’s National Microbiology Laboratory.

IAVI initially developed its rVSV vector for HIV vaccine candidates and has since expanded its use to the development of vaccines addressing emerging infectious diseases (Lassa Fever, Marburg, Sudan ebolavirus, and COVID-19).

Funders who have made the development of IAVI’s rVSV-vectored vaccine candidates possible include the Bill & Melinda Gates Foundation; the Government of Canada; the Danish Ministry of Foreign Affairs; the Government of Japan; the Irish Department of Foreign Affairs and Trade; the Netherlands Ministry of Foreign Affairs; the Norwegian Agency for Development Cooperation; the U.K Department for International Development; the U.S. National Institutes of Health; and through the generous support of the American people from the United States Agency for International Development.

This project is funded in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority under contract number 75A50121C00077.

[1] https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON410

[2] https://link.springer.com/article/10.1007/s11262-017-1455-x

[3] https://cdn.who.int/media/docs/default-source/blue-print/who-vaccine-prioritization-report-uganda-ebola-trial-nov-16-2022.pdf

SOURCE: IAVI

ePac Flexible Packaging Announces the Official Opening of its Plant in Accra, Ghana

Global company ready to serve brands of all sizes throughout West Africa

Austin, Texas USA, June 26, 2023 (GLOBE NEWSWIRE) — ePac Flexible Packaging, an industry leader in custom flexible packaging, is pleased to announce the opening of its new Grade A 2,200 square meter production plant on the Spintex Road in Accra, Ghana. A grand opening celebration was held on June 22nd with nearly 150 local dignitaries, government officials, customers, and media in attendance.

Since its establishment  in 2021, ePac West Africa, has served a number of customers across Africa, including customers from Ghana, Nigeria, Senegal and Zanzibar, with fulfillment handled by ePac’s plants in the UK and Lyon, France. With the opening of the new plant, ePac West Africa is uniquely positioned to serve CPG brands of all sizes throughout the region with competitively priced flexible packaging and industry best turnaround times.

According to Victor Sosah, General Manager of ePac West Africa: “ePac is poised to serve the West African community with the highest quality packaging that has been proven to help small
and medium enterprises grow. With our first facility in the region located in Ghana, we can help our customers, and consumers alike,  “buy-local” in support of the government initiatives to increase local food manufacturing and reduce imports”.

Mr. Sosah added: “No longer will local brands need to accept inferior packaging, or source it from overseas. With ePac’s all-digital platform we’re able to reduce lead times on packaging orders from months to 15 business days (following artwork approval), while enabling brands to order to demand and avoid costly excess inventory and obsolescence”.

According to ePac CEO Jack Knott: “the opening of the plant in Ghana represents a significant milestone in ePac’s global expansion. I am excited that we are able to provide a great packaging option which allows brands to compete for space on local supermarket shelves and introduce new products to international markets.”

About ePac:
ePac is the world’s largest networked flexible packaging provider, serving brands of all sizes across the globe. Founded in 2016, ePac began with a single plant in Madison, Wisconsin serving predominantly community-based small and medium sized brands. Today, through its proprietary technology platform – ePacONE (One Network Everywhere), ePac provides brands, large and small alike, the ability to produce any size order anywhere across its 25 facilities across the globe.

ePac offers a full complement of sustainable film options, while its print technology platform is carbon-neutral and inherently eco-friendly. Further, the company offers true order to demand capability, helping brands reduce inventory and obsolescence.

Attachments

Carl Joachim
ePac Flexible Packaging
+1 561-573-7992
cjoachim@ePacFlexibles.com

Victor Sosah
ePac West Africa
+233 501 333 162
vsosah@ePacFlexibles.com

CFI Forms Exclusive Partnership with Grant Thornton Ethiopia to Empower Finance and Banking Professionals, Prepare for Capital Markets

VANCOUVER, British Columbia, June 22, 2023 (GLOBE NEWSWIRE) — Corporate Finance Institute (CFI), a leading provider of practical learning and productivity tools for finance and banking professionals, today announced it has partnered with Grant Thornton Ethiopia as an exclusive agent of CFI’s online programs and certifications in Ethiopia.

The partnership is designed to train new workforces, bridge existing skill gaps, and enable finance professionals to embrace the opportunities presented by the formal introduction of capital markets in Ethiopia expected to begin in 2024.

“We’re excited to work with Grant Thornton Ethiopia to make our internationally recognized programs available for the Ethiopian market,” said CFI CEO Anna Talerico. “This partnership really emphasizes the core of our mission at CFI — to deliver high-quality, skills-oriented training that’s self-paced and can be consumed from anywhere with an internet connection.

Embracing digital transformation that’s disrupting traditional classroom-style learning doesn’t only improve access to education, Talerico added — it also allows CFI to regularly update its catalog to keep pace with industry changes and rapidly deliver that value to members.

CFI’s programs feature a collection of accredited certifications and specializations — including the company’s flagship Financial Modeling & Valuation Analyst (FMVA) certification — each of which offers the knowledge and hands-on skills needed to thrive in dozens of corporate finance and banking career paths.

“Grant Thornton Ethiopia is pleased to collaborate with Corporate Finance Institute,” said Melaku Abeje, Managing Partner at Grant Thornton Ethiopia. “CFI’s hands-on certification and specialization programs have huge potential to fill the skill gap among banking and finance professionals in the realm of capital market operation.”

With more than 150 on-demand courses containing more than 5,000 lessons, CFI’s expert-led programs are delivered through a single platform that enables learners to work at their own pace while honing in on the skills that are most relevant to their daily roles.

“I recently completed the FMVA courses provided by CFI and it was truly a game-changer for my career in corporate finance,” said Samrawit Minilik, Associate, Transaction Advisory Services at Grant Thornton Ethiopia. “The content was incredibly helpful and relevant to my day-to-day responsibilities — especially areas related to financial modeling and Excel skills. I would highly recommend it to anyone looking to advance their career in finance.”

CFI has trained millions of finance and banking professionals in more than 170 countries. To learn more about the company’s certifications and training programs, visit www.corporatefinanceinstitute.com.

About CFI
CFI is a world-leading provider of practical learning and productivity tools for finance and banking professionals. Featuring expert instructors, hands-on lessons, and practical skills training, CFI delivers the certifications, CPE credits, and resources to help anyone — from beginners to seasoned professionals — drive their finance career.

About Grant Thornton Ethiopia
Grant Thornton Ethiopia, a member of Grant Thornton International established 100 years ago, is Ethiopia’s leading Advisory, Assurance and Tax service provider dedicated to serving the needs of privately held businesses and public interest entities. We have got scale, combined with over 40 years of local experience and hands-on exposure to the local market and business ecosystem. GTE has significant experience in advising clients on IPO readiness assessment, business valuation, capacity building, talent acquisition, trading system deployment, M&A, investment banking and brokerage arm establishment, corporate governance, and many other services in capital market space.

CFI Media Contact
press@corporatefinanceinstitute.com

GlobeNewswire Distribution ID 8862274

New Study: Failing Global Debt System Costs Lives

New York, June 22, 2023 (GLOBE NEWSWIRE) — New research supported by the Open Society Foundations shows that increasing delays in resolving sovereign debt crises in some of the world’s poorest countries are significantly adding to the human cost of defaults—cutting economic growth, reducing life-expectancy, and worsening child mortality rates.

The analysis, The Human Costs of the Failing Global Debt System, builds on research published last year that showed how going into default leads to economic and human damage that worsens over subsequent years.

Sovereign debt defaults occur when countries fail to pay their debts on time. This can be interest or principal payments to domestic or international creditors. This typically forces a renegotiation of lending terms. The research looked at data from 131 sovereign debt defaults around the world since 1900.

The new paper’s authors, economists Clemens Graf von Luckner and Juan P. Farah-Yacoub, conclude that, in addition, the longer it takes a country to reach a new agreement with its creditors, the greater the increase in human costs:

  • When a country’s debt crisis is resolved in less than three years, infant mortality ten years after a default is declared as 2.2 percentage points higher than would have been expected. But when the default continues for more than three years, the difference rises to a staggering 11.4 percentage points higher.
  • For the countries studied, on average, life expectancy ten years after default drops by more than one year relative to where it would have been without the default.
  • In addition, the shortfall in the rate of increase in real economic output per capita (against what it could have been without default), jumps by 2.5 percentage points in the first year of default, against what it would have been had there been no default. It then continues to grow by 1.5 percentage point on average each year thereafter. Over a decade the gap grows to roughly 14.5 percentage points.

The findings underline the grave damage being caused by the failure of the existing global financial system to deliver prompt resolution to countries in default due in part to the involvement of an increasingly complex mix of creditors—including international financial institutions such as development banks, commercial banks, sovereign lenders including China, and private commercial creditors.

The report also highlights the case of Zambia, which defaulted on its external debt in November 2020 under the economic strains of the Covid pandemic. It has yet to secure a comprehensive debt agreement among all of its public and private creditors and the International Monetary Fund, with its total debt now estimated at over $18 billion.

The authors of this new report calculated that, based on a calculation using Zambia’s birth rates in 2016, the country’s current debt default would result in an additional 3,079 annual deaths of infants before their first birthdays by the year 2030, if the default is prolonged further.

Mark Malloch-Brown, president of the Open Society Foundations, said: “The findings here starkly illustrate how a dysfunctional global financial system is causing tragic but entirely avoidable human suffering. The leaders meeting in Paris need to commit to the urgent reforms the world needs to face both deepening poverty and the worsening climate crisis.”

The Open Society Foundations, together with a broad range of civil society groups, are pushing for the leaders gathered at the Summit for a New Global Financing Pact in Paris to commit to policies that will significantly reform the international debt restructuring process to allow for a just and sustainable resolution to a country’s default delivered in a timely manner. These steps include:

  1. States establishing a clear process with firm timetables for getting agreement to “cure” defaults—no more three years in limbo like Zambia.
  2. The IMF must more aggressively use its authority to “lend into arrears”—which means they can launch their funding support program to indebted countries even if some creditors refuse to accept new debt relief terms. These hold out creditors loans would not get paid, but everyone else participating does.
  3. Private creditors (including sovereign bond holders) should not be allowed to refuse to accept debt settlements that creditor countries agree to, and then expect to be paid with the benefits of that relief, or to use the courts to get full repayment. In the United States, the New York State legislature has before it legislation that would end this practice.
  4. The International Financial Institutions need significantly more funding from the Global North to give them the resources needed to properly fund recovery from defaults and allow the economic growth needed to avoid defaults in the future.
Office of Communications
Open Society Foundations 
(212) 548-0378
media@opensocietyfoundations.org

GlobeNewswire Distribution ID 8862959

FreedomPay Partners with Visa to Offer Global Omnichannel Network Tokenization

Philadelphia, Pennsylvania, June 22, 2023 (GLOBE NEWSWIRE) — FreedomPay, a global leader in Next Level Commerce™, announces a partnership with Visa to integrate Visa’s network tokenization capabilities within FreedomPay’s global identity and tokenization framework. The true omnichannel global tokenization product will provide network tokens across card brands, helping to keep merchants compliant with cross-border and in-region data and privacy regulations, while helping merchants qualify for lower interchange rates for certain Visa network tokenized transactions.

“With the growing number of connected devices, changing consumer behaviors and shifting privacy regulations, the benefits of utilizing network tokens are many. Using the Visa Acceptance Platform, Visa has the scale and flexibility to seamlessly provision them for FreedomPay’s clients around the globe, helping to improve customer experience, improve authorization rates and reduce fraud,” said Bill Dobbins, SVP, Head of Acquiring and Enablement at Visa.

Network tokenization will also help streamline the customer journey, providing a seamless experience across borders and merchant locations. The new capabilities will be integrated into FreedomPay’s larger identity suite, offering a 360-degree view of the customer to the merchant, creating a more personalized checkout experience through data-driven loyalty and incentives.

“FreedomPay is trusted by the largest brands across hospitality, retail, F&B and more to provide repeatable and scalable next level solutions for security, data management and compliance, and to create a personalized and seamless customer journey around the globe,” said David Knowlton, CTO at FreedomPay. “By partnering with Visa for network tokenization, FreedomPay will provide merchants with more flexibility and geographic coverage, including in harder-to-access regions, when managing customer and card data.”

Additional features will also be supported without any changes to the merchant’s systems such as supporting card on file use cases with digital wallet taps as well as token life cycle management.

About FreedomPay

FreedomPay’s Next Level Commerce™ platform transforms existing payment systems and processes from legacy to leading edge and enables merchants to unleash the power of pay. As the premier choice for many of the largest companies across the globe in retail, hospitality, lodging, gaming, sports and entertainment, foodservice, education, healthcare and financial services, FreedomPay’s technology has been purposely built to deliver rock solid performance in the highly complex environment of global commerce.

The company maintains a world-class security environment and was first to earn the coveted validation by the PCI Security Standards Council against Point-to-Point Encryption (P2PE/EMV) standard in North America. FreedomPay’s robust solutions across payments, security, identity, and data analytics are available in-store, online and on-mobile and are supported by rapid API adoption. The award winning FreedomPay Commerce Platform operates on a single, unified technology stack across multiple continents allowing enterprises to deliver an innovative Next Level experience on a global scale. www.freedompay.com

Jennifer Tayebi
Hill+Knowlton Strategies for FreedomPay
+1 734 395 0780
jennifer.tayebi@hkstrategies.com

GlobeNewswire Distribution ID 8862332

Deriv’s philanthropic venture: Driving social change through sponsorship of 4L Trophy

The 6,000 km rally over 10 days took place in February this year, starting in France and concluding in Morocco, with the aim of helping underprivileged children in Africa.

Deriv sponsored 2 drivers for the 2023 edition of the 4L Trophy rally.

Deriv sponsored team in action during the 4L Trophy rally.

PARIS, June 22, 2023 (GLOBE NEWSWIRE) — Deriv, one of the leading online brokers, has been actively participating in humanitarian efforts that are aligned with its core values of being reliable, fair, transparent, and responsible. Earlier this year, Deriv sponsored a team of two young professionals who successfully completed the 4L Trophy rally, an annual humanitarian car rally that raises funds for the cause of underprivileged children in Africa.

The 4L Trophy rally started in France and ended in Morocco, covering a 6,000 km journey over 10 days. It required participants to drive through challenging terrain, navigating their way through various checkpoints. A long journey for a noble cause: deliver stationery and textbooks for underprivileged children along the way.

Deriv humanitarian ride through the desert in Morocco.

Deriv humanitarian ride through the desert in Morocco.

“The challenges of navigating unfamiliar terrain, camping in the middle of nowhere, and crossing the finish line were thrilling and rewarding,” Clement David, one of the drivers sponsored by Deriv, said. “But what made the experience truly special was the opportunity to make a difference in children’s lives by delivering much-needed school supplies.”

Deriv supports humanitarian drive in Morocco during the 4L Trophy rally.

Deriv-sponsored team interacts with children in need in Morocco during the course of the 4L Trophy rally.

Jean-Yves Sireau, founder and CEO of Deriv, said: “Deriv’s participation in the 4L Trophy rally is a testament to our commitment to making a positive impact on the communities we serve. We believe in supporting causes that empower individuals and communities to thrive, and education is a critical component of that.”

“We believe that businesses have a responsibility to give back to society,” added Sireau. “Through our philanthropic efforts, we hope to inspire other organisations to do their part in making the world a better place.”

Deriv-sponsored team distributed humanitarian aid to children in need in Morocco.

Deriv supports humanitarian drive in Morocco during the 4L Trophy rally.

The 4L Trophy rally is just one example of Deriv’s involvement in humanitarian initiatives. Earlier this year, the company had also donated 11 boxes of clothes to Fundacion Unidos por Cristo (Asunción, Paraguay), a residential home that provides comprehensive care to children and adolescents at risk.

To learn more about Deriv and its humanitarian initiatives, follow Derivlife and the company’s Instagram account.

About Deriv

Deriv started its journey in 1999. Its mission since has been to make online trading accessible to anyone, anywhere. Deriv’s product offering includes intuitive trading platforms, over 200 tradable assets (in markets such as forex, stocks, and cryptocurrencies), unique trade types, and more. Deriv embraces its commitment to the community, elevating its humanitarian initiatives to new heights across its network of 20 offices spanning 16 countries.

PRESS CONTACT
Aleksandra Zuzic
aleksandra@deriv.com

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/84da82a4-68fe-4100-b936-f179348cbb9e
https://www.globenewswire.com/NewsRoom/AttachmentNg/61b1b768-e495-4845-aaaa-b96adda137a6

GlobeNewswire Distribution ID 1000826460